Search Browse Earnings

ENDONOVO THERAPEUTICS, INC.

OTC:ENDV

Electromedical & Electrotherapeutic Apparatus·WOODLAND HILLS, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Collier Alan Brian

Revenue

$73,105

-55.9% YoY

FY 2022

Adj. EBITDA

-$1.6M

-2158.6% margin

FY 2022

Net Income

-$3.1M

-4247.2% margin

FY 2022

EPS (Diluted)

-$0.05

FY 2022

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$13,420

FY 2021

Total Debt

$7.2M

FY 2022

Net Debt

$7.2M

FY 2022

Enterprise Value

—

Debt / EBITDA

-4.5x

FY 2022

EV / EBITDA

—

Employees

—